GNTA
Genenta Science S.p.A. - American Depositary Shares (GNTA)
$96
About Genenta Science S.p.A. - American Depositary Shares (GNTA)
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
Details
Daily high
$3.98
Daily low
$3.80
Price at open
$3.82
52 Week High
$7.28
52 Week Low
$2.74
Market cap
71.3M
Dividend yield
0.00%
Volume
5,332
Avg. volume
31,681
P/E ratio
-7.39
Genenta Science S.p.A. - American Depositary Shares News
Details
Daily high
$3.98
Daily low
$3.80
Price at open
$3.82
52 Week High
$7.28
52 Week Low
$2.74
Market cap
71.3M
Dividend yield
0.00%
Volume
5,332
Avg. volume
31,681
P/E ratio
-7.39